Traditional Wound Management Market (By Product: Gauze, Tapes, Cotton; By Application: Chronic, Acute Wounds; By End-use: Hospitals, Home Healthcare) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2023-2032

The global traditional wound management market was surpassed at USD 6.25 billion in 2022 and is expected to hit around USD 8.99 billion by 2032, growing at a CAGR of 3.7% from 2023 to 2032.

Traditional Wound Management Market Size 2023 to 2032

Key Pointers

  • The gauze segment accounted for the largest share of more than 48.96% of the overall revenue in 2022.
  • The acute wounds segment held the largest share of around 60.03% of the overall revenue in 2022.
  • The hospitals segment dominated the global industry in 2022 and accounted for the largest share of more than 45.11% of the overall revenue.
  • North America dominated the global industry in 2022 with a revenue share of more than 45.05%.
Report Coverage Details
Market Size in 2022 USD 6.25 billion
Revenue Forecast by 2032 USD 8.99 billion
Growth rate from 2023 to 2032 CAGR of 3.7%
Base Year 2022
Forecast Period 2023 to 2032
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Covered 3M; ConvaTec Group PLC; DermaRite Industries LLC; DeRoyal Industries Inc.; Hollister Inc.; Integra LifeSciences Holdings Corp.; Coloplast A/S; Medtronic plc; Mölnlycke Health Care AB; Smith & Nephew plc.; B. Braun Melsungen AG; PAUL HARTMANN AG; Johnson & Johnson Pvt. Ltd.

 

The growth of the market is attributed to the increasing number of accidents, the rising number of Ambulatory Surgical Centers (ASCs), and the increase in the prevalence of chronic diseases across the globe. The prevalence of chronic diseases, such as urological disorders, cancer, Cardiovascular Disorders (CVDs), neurovascular diseases, and other chronic problems, is increasing. Chronic diseases are responsible for around 60% of all fatalities worldwide, according to the WHO.

A significant percentage of the population is currently in danger of developing chronic diseases as a result of high blood pressure, obesity, smoking habits, diabetes, a sedentary lifestyle, and excessive alcohol consumption. Every year, 17.9 million people die due to CVDs worldwide. In addition, according to the National Diabetes Statistic Report 2017, published by the Centers for Disease Control and Prevention (CDC), more than 100.0 million people in the U.S. had diabetes or prediabetes conditions. In addition, IDF reported that the global diabetes prevalence in individuals aged 20 to 79 years in 2021 was projected to be 10.5% (536.6 million people), increasing to 12.2% (783.2 million) in 2045.

Furthermore, cancer has been a major contributor to the global healthcare burden and is one of the leading causes of death. According to estimates from WHO, cancer is a leading cause of death globally, with almost 1 in 6 deaths attributed to the disease. In addition, it also reported that over 70% of cancer-related deaths typically occur in middle- and low-income countries. As a result of the rising prevalence of chronic conditions, the number of surgeries being performed has also increased. Traditional wound care products, such as cotton, gauze, tapes, and bandages, are, thus, increasingly being used to prevent surgical-site infections. ASCs offer a variety of services, such as surgical care, diagnostics, and preventive procedures.

Few market participants reported a drop in sales in 2020 as a result of the pandemic. In addition, governments of major nations reassigned healthcare resources in wound clinics, including beds, nurses, and critical professionals, to handle COVID-19 patients in the first part of the year. As a result, wound treatment was removed from the list of necessary procedures. Several medical organizations also released guidelines for treating patients with difficult-to-heal wounds. 

However, post-pandemic the market is regaining its momentum and is likely to grow at a considerable pace in the forecast period. This is mainly owing to the surge in demand for home healthcare, strategic initiatives adopted by key players, rising adoption of telemedicine, and rapid penetration of the e-commerce industry.

Market Segmentation

By Product

  • Gauze
  • Tape
  • Bandages
  • Cotton

By Application

  • Chronic Wounds
    • Diabetic Foot Ulcers
    • Pressure Ulcers
    • Venous Leg Ulcers
    • Other Chronic Wounds
  • Acute Wounds
    • Surgical & Traumatic Wounds
    • Burns

By End-use

  • Hospitals
  • Clinics
  • Home Healthcare
  • Others

Frequently Asked Questions

The global traditional wound management market size was reached at USD 6.25 billion in 2022 and it is projected to hit around USD 8.99 billion by 2032.

The global traditional wound management market is growing at a compound annual growth rate (CAGR) of 3.7% from 2023 to 2032.

The North America region has accounted for the largest traditional wound management market share in 2022.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Traditional Wound Management Market 

5.1. COVID-19 Landscape: Traditional Wound Management Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Traditional Wound Management Market, By Product

8.1. Traditional Wound Management Market, by Product, 2023-2032

8.1.1 Gauze

8.1.1.1. Market Revenue and Forecast (2019-2032)

8.1.2. Tape

8.1.2.1. Market Revenue and Forecast (2019-2032)

8.1.3. Bandages

8.1.3.1. Market Revenue and Forecast (2019-2032)

8.1.4. Cotton

8.1.4.1. Market Revenue and Forecast (2019-2032)

Chapter 9. Global Traditional Wound Management Market, By Application

9.1. Traditional Wound Management Market, by Application, 2023-2032

9.1.1. Chronic Wounds

9.1.1.1. Market Revenue and Forecast (2019-2032)

9.1.2. Acute Wounds

9.1.2.1. Market Revenue and Forecast (2019-2032)

Chapter 10. Global Traditional Wound Management Market, By End-use 

10.1. Traditional Wound Management Market, by End-use, 2023-2032

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2019-2032)

10.1.2. Clinics

10.1.2.1. Market Revenue and Forecast (2019-2032)

10.1.3. Home Healthcare

10.1.3.1. Market Revenue and Forecast (2019-2032)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2019-2032)

Chapter 11. Global Traditional Wound Management Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2019-2032)

11.1.2. Market Revenue and Forecast, by Application (2019-2032)

11.1.3. Market Revenue and Forecast, by End-use (2019-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2019-2032)

11.1.4.2. Market Revenue and Forecast, by Application (2019-2032)

11.1.4.3. Market Revenue and Forecast, by End-use (2019-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2019-2032)

11.1.5.2. Market Revenue and Forecast, by Application (2019-2032)

11.1.5.3. Market Revenue and Forecast, by End-use (2019-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2019-2032)

11.2.2. Market Revenue and Forecast, by Application (2019-2032)

11.2.3. Market Revenue and Forecast, by End-use (2019-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2019-2032)

11.2.4.2. Market Revenue and Forecast, by Application (2019-2032)

11.2.4.3. Market Revenue and Forecast, by End-use (2019-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2019-2032)

11.2.5.2. Market Revenue and Forecast, by Application (2019-2032)

11.2.5.3. Market Revenue and Forecast, by End-use (2019-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2019-2032)

11.2.6.2. Market Revenue and Forecast, by Application (2019-2032)

11.2.6.3. Market Revenue and Forecast, by End-use (2019-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2019-2032)

11.2.7.2. Market Revenue and Forecast, by Application (2019-2032)

11.2.7.3. Market Revenue and Forecast, by End-use (2019-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2019-2032)

11.3.2. Market Revenue and Forecast, by Application (2019-2032)

11.3.3. Market Revenue and Forecast, by End-use (2019-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2019-2032)

11.3.4.2. Market Revenue and Forecast, by Application (2019-2032)

11.3.4.3. Market Revenue and Forecast, by End-use (2019-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2019-2032)

11.3.5.2. Market Revenue and Forecast, by Application (2019-2032)

11.3.5.3. Market Revenue and Forecast, by End-use (2019-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2019-2032)

11.3.6.2. Market Revenue and Forecast, by Application (2019-2032)

11.3.6.3. Market Revenue and Forecast, by End-use (2019-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2019-2032)

11.3.7.2. Market Revenue and Forecast, by Application (2019-2032)

11.3.7.3. Market Revenue and Forecast, by End-use (2019-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2019-2032)

11.4.2. Market Revenue and Forecast, by Application (2019-2032)

11.4.3. Market Revenue and Forecast, by End-use (2019-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2019-2032)

11.4.4.2. Market Revenue and Forecast, by Application (2019-2032)

11.4.4.3. Market Revenue and Forecast, by End-use (2019-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2019-2032)

11.4.5.2. Market Revenue and Forecast, by Application (2019-2032)

11.4.5.3. Market Revenue and Forecast, by End-use (2019-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2019-2032)

11.4.6.2. Market Revenue and Forecast, by Application (2019-2032)

11.4.6.3. Market Revenue and Forecast, by End-use (2019-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2019-2032)

11.4.7.2. Market Revenue and Forecast, by Application (2019-2032)

11.4.7.3. Market Revenue and Forecast, by End-use (2019-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2019-2032)

11.5.2. Market Revenue and Forecast, by Application (2019-2032)

11.5.3. Market Revenue and Forecast, by End-use (2019-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2019-2032)

11.5.4.2. Market Revenue and Forecast, by Application (2019-2032)

11.5.4.3. Market Revenue and Forecast, by End-use (2019-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2019-2032)

11.5.5.2. Market Revenue and Forecast, by Application (2019-2032)

11.5.5.3. Market Revenue and Forecast, by End-use (2019-2032)

Chapter 12. Company Profiles

12.1. 3M

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. ConvaTec Group PLC

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. DermaRite Industries LLC

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. DeRoyal Industries Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Hollister Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Integra LifeSciences Holdings Corp.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Coloplast A/S

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Medtronic plc

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Mölnlycke Health Care AB

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Smith & Nephew plc.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers